Suven Life Sciences Stock Screener | Share Price & Fundamental Analysis
SUVEN
Healthcare Technology
Share Price NSE
₹166.87
▼
-0.97 (-0.58%)
Share Price BSE
₹167.15
▼
-0.75 (-0.45%)
Track Suven Life Sciences share price live with TickJournal's free stock screener.
Analyze Suven Life Sciences share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Suven Life Sciences Market Cap
₹3,663.91 Cr.
SUVEN P/E Ratio (TTM)
-14.16
Suven Life Sciences P/B Ratio
5.07
EPS (TTM)
₹-7.37
Dividend Yield
-
Debt to Equity
-
SUVEN 52 Week High
₹233.36
Suven Life Sciences 52 Week Low
₹126.65
Operating Margin
-3678.00%
Profit Margin
-1700.00%
SUVEN Revenue (TTM)
₹6.00
EBITDA
₹-101.00
Net Income
₹-102.00
Total Assets
₹135.00
Total Equity
₹110.00
Suven Life Sciences Share Price History - Stock Screener Chart
Screen SUVEN historical share price movements with interactive charts. Analyze price trends and patterns.
Suven Life Sciences Company Profile - Fundamental Screener
Screen Suven Life Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SUVEN shares.
Sector
Healthcare
Industry
Healthcare Technology
Sub-Sector
Healthcare Technology
Segment
E
ISIN
INE495B01038
Suven Life Sciences Balance Sheet Screener
Screen SUVEN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 135 | 285 | 389 | 108 | 128 | 182 | 303 | 919 | 816 | 752 |
| Current Assets | 76 | 257 | 252 | 67 | 103 | 66 | 281 | 570 | 492 | 428 |
| Fixed Assets | 60 | 28 | 37 | 38 | 21 | 25 | 22 | 308 | 306 | 305 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 1 | 3 | 4 | 5 | 12 | 25 | 30 | 30 | 46 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 110 | 270 | 375 | 96 | 108 | 143 | 239 | 767 | 667 | 595 |
| Share Capital | 22 | 22 | 22 | 15 | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves & Surplus | 88 | 248 | 354 | 82 | 58 | 131 | 226 | 755 | 654 | 583 |
Suven Life Sciences Income Statement Screener - Profit & Revenue Analysis
Screen Suven Life Sciences income statement and profit fundamentals.
Analyze SUVEN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Suven Life Sciences share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6 | 5 | 3 | 3 | 3 | 7 | 5 | 7 | 9 | 16 | 9 | 8 | 5 | 5 | 10 |
| Expenses | 106 | 81 | 53 | 45 | 41 | 55 | 32 | 33 | 49 | 27 | 32 | 34 | 55 | 26 | 25 |
| EBITDA | -101 | -76 | -50 | -43 | -38 | -48 | -27 | -26 | -40 | -11 | -22 | -26 | -49 | -22 | -15 |
| Operating Profit % | -3678.00% | -8671.00% | -2714.00% | -2981.00% | -2435.00% | -2032.00% | -3023.00% | -1267.00% | -1885.00% | -768.00% | -737.00% | -1208.00% | -1720.00% | -494.00% | -595.00% |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -102 | -77 | -52 | -44 | -39 | -50 | -28 | -28 | -42 | -13 | -24 | -28 | -51 | -23 | -16 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -102 | -77 | -52 | -44 | -39 | -50 | -28 | -27 | -42 | -13 | -24 | -28 | -51 | -23 | -16 |
| EPS | -4.55 | -3.48 | -2.36 | -2.02 | -1.79 | -2.27 | -1.29 | -1.22 | -1.92 | -0.58 | -1.10 | -1.17 | -2.90 | -1.51 | -1.12 |
Suven Life Sciences Cash Flow Screener - Liquidity Fundamentals
Screen SUVEN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -154 | -116 | -116 | -128 | -96 | -135 | -53 | 70 | 109 | 68 |
| Investing Activities | 155 | 94 | -248 | -22 | 56 | 146 | 30 | -1 | -311 | -39 |
| Financing Activities | -1 | -1 | 396 | 146 | 35 | 3 | 5 | -52 | -30 | -68 |
| Net Cash Flow | 0 | -22 | 32 | -4 | -5 | 14 | -18 | 17 | -232 | -39 |
Suven Life Sciences Shareholding Pattern Screener
See Suven Life Sciences shareholding pattern with promoter, FII, and DII holdings.
Check Suven Life Sciences promoter holding and ownership changes for SUVEN on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Jul | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 70.15% | 70.27% | 70.27% | 67.43% | 67.36% | 67.36% | 69.57% | 70.27% |
| FII Holding | 0.81% | 0.25% | 0.59% | 0.56% | 1.18% | 1.07% | 0.46% | 0.45% |
| DII Holding | 4.62% | 0.01% | 0.02% | 3.41% | 3.39% | 3.39% | 1.17% | 1.17% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 19.51% | 24.04% | 23.17% | 22.24% | 22.25% | 22.29% | 22.29% | 22.66% |
| Other Holding | 4.91% | 5.44% | 5.95% | 6.37% | 5.82% | 5.90% | 6.51% | 5.46% |
| Shareholder Count | 64,037 | 64,603 | 66,159 | 65,574 | 64,921 | 64,381 | 68,959 | 66,116 |
Suven Life Sciences Share Dividend Screener - Share Yield Analysis
Check Suven Life Sciences dividend history with payout and yield data.
View Suven Life Sciences dividend details including ex-dates and amounts for SUVEN stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹1.50 | 7.61% |
| 2018-March | ₹1.50 | 0.57% |
| 2017-March | ₹1.00 | 12.85% |
Suven Life Sciences Stock Index Membership
See which indices include Suven Life Sciences stock.
Check SUVEN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
Suven Life Sciences Market Events Screener - Corporate Actions
Get Suven Life Sciences corporate actions including splits, bonuses, and buybacks.
Check Suven Life Sciences stock events that may affect SUVEN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-01-29 | 2026-01-29 | Quarterly Result Announcement | NA | -2.40% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -5.22% |
| 2025-08-22 | 2025-08-22 | Annual General Meeting | NA | 53.37% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -13.24% |
| 2025-06-05 | 2025-06-05 | Extraordinary General Meeting | NA | 53.37% |
| 2025-05-13 | 2025-05-13 | Quarterly Result Announcement | NA | 16.60% |
| 2025-01-24 | 2025-01-24 | Quarterly Result Announcement | NA | -8.29% |
| 2024-10-29 | 2024-10-29 | Quarterly Result Announcement | NA | -7.61% |
| 2024-08-02 | 2024-08-02 | Annual General Meeting | NA | 26.09% |
| 2022-10-17 | 2022-10-18 | Rights | 1:2 | 4.83% |
Suven Life Sciences Competitors Screener - Peer Comparison
Screen SUVEN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Syngene International | 15,759 | 45.35 | 3,714 | 3.77% | 496 | 37.62 |
| Indegene | 11,381 | 25.50 | 2,947 | 10.53% | 407 | 54.95 |
| Suven Life Sciences | 3,664 | -14.16 | 18 | -46.34% | -161 | 64.97 |
| Vimta Labs | 1,827 | 29.61 | 322 | 0.22% | 41 | 43.60 |
| Take Solutions | 610 | 367.45 | 10 | 126.67% | 1 | 54.56 |
| Bilcare | 132 | -3.12 | 807 | 4.78% | -56 | 46.05 |
| Jeevan Scientific Technology | 127 | -60.98 | 48 | 17.87% | 0 | 48.35 |
| Adeshwar Meditex | 25 | 33.09 | 84 | 5.00% | 2 | 23.84 |
| Vanta Bioscience | 11 | -0.81 | 2 | -78.57% | -13 | 18.83 |
Suven Life Sciences Company Announcements - News Screener
Screen SUVEN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-03-30 | Closure of Trading Window | - |
| 2026-03-09 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-06 | Board Meeting Outcome for ALLOTMENT OF 31768764 EQUITY SHARES OF THE COMPANY ON PREFERENTIAL BASIS | - |
| 2026-03-06 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-02-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-06 | Clarification On Price Movement | - |
| 2026-02-05 | Clarification sought from Suven Life Sciences Ltd | - |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-01-29 | Appointment of Company Secretary and Compliance Officer | - |
| 2026-01-29 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | - |
| 2026-01-29 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-01-29 | Board Meeting Outcome for Outcome Of The Board Meeting | - |
| 2026-01-29 | Outcome Of The Meeting Of Board Of Directors Of Suven Life Sciences Limited Held On Thursday January 29 2026 | - |
| 2026-01-22 | Board Meeting Intimation for To Consider And Approve The Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2025 And Related Matters | - |
| 2026-01-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-29 | Closure of Trading Window | - |
| 2025-12-11 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |